Author Question: Henry Fayol is known as the father of bureaucracy. A. True B. ... (Read 70 times)

pragya sharda

  • Hero Member
  • *****
  • Posts: 566
Henry Fayol is known as the father of bureaucracy.
 
  A. True
  B. False

Question 2

In 1994, Congress enacted the Second Chance Act providing incentive grants to states that adopted truth-in-sentencing laws.
 
  a. True
  b. False



mtmmmmmk

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

FALSE

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

pragya sharda

  • Hero Member
  • *****
  • Posts: 566
Both answers were spot on, thank you once again



mtmmmmmk

  • Sr. Member
  • ****
  • Posts: 335
Great! Please up vote :D



 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library